Name	Qualifications	Conflict of Interest
Alain Lesage	MD, FRCPC, MPhil, DFAPA Professor, Department of Psychiatry, University of Montreal Psychiatrist and researcher, Centre de recherche Fernand-Seguin Institut universitaire en santé mentale de Montréal	No conflict of interest to disclose
Austin Mardon	PhD, CM, LLD (Hon) Assistant Adjunct Professor, John Dossetor Health Ethics Centre, University of Alberta, Edmonton, AB	No conflict of interest to disclose
Chris Summerville	D.Min., CPRP Chief Executive Officer Schizophrenia Society of Canada / Societe Canadienne de la Schizophrenie	No conflict of interest to disclose
Donald Addington	MBBS, MRCPsych, FRCPC Professor, Department of Psychiatry, University of Calgary Mathison Centre for Research & Education Department of Psychiatry	No conflict of interest to disclose
Doug Urness	MD, LMCC, FRCPC Clinical Department Head, Addiction and Mental Health Program, Central Zone, Alberta Health Services	No conflict of interest to disclose
Gary Remington	Schizophrenia Program Director Centre for Addiction and Mental Health University of Toronto	Participated in the development of one of the selected guidelines (Optimal Use Recommendations for Atypical Antipsychotics: Combination and High-Dose. Presenting the results at the CPA 2013 and CAMH Grand rounds – 2013. Has worked as a consultant for Novartis and Laboratorios Farmaceuticos Rovi Has worked as consultant and Speaker’s honoraria for Novartis
Iliana Garcia-Ortega	MD, Psychiatrist Research Associate	No conflict of interest to disclose
Jean Addington	Professor, University of Calgary Mathison Centre for Mental Health Research and Education	No conflict of interest to disclose
Kevin Jackson	Family Member	No conflict of interest to disclose
Kim Jackson	Family Member Corporate Secretary and Investor Relations Associate	No conflict of interest to disclose
Martina Ann Kelly	Clerkship Director, Department of Family Medicine University of Calgary Health Sciences Centre	No conflict of interest to disclose
Michael Teehan	Associate Professor Department of Psychiatry Early Psychosis Program Dalhousie University	No conflict of interest to disclose
Ross Norman	Professor, Western University Department of Psychiatry - PEPP Psychosis Program Department of Epidemiology & Biostatistics	No conflict of interest to disclose
Sabina Abidi	MD FRCP Assistant Professor Division Head, Outpatient Services, IWK Mental Health & Addictions Program Head, IWK Youth Psychosis Program	No conflict of interest to disclose
Tamara Milka Pringsheim	MD, FRCPC Neurology Associate Professor, University of Calgary Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences Evidence Based Medicine Methodologist, American Academy of Neurology	No conflict of interest to disclose
William Honer	MD, FRCPC, FCAHS Jack Bell Chair in Schizophrenia Professor and Head, Department of Psychiatry Director, Institute of Mental Health University of British Columbia	Academic/expert consultant on Optimal Use Recommendations for Atypical Antipsychotics: Combination and High-Dose Treatment Strategies in Adolescents and Adults with Schizophrenia (CADTH); presentation of work at Canadian Psychiatric Association meeting. Consultant to Silico Biosciences, Otsuka, Lundbeck, Roche and Lilly. Honoraria from CADTH, Otsuka, Lundbeck, Roche and Lilly.
Zahinoor Ismail	MD FRCPC Clinical Associate Professor, University of Calgary Assistant Professor, University of Toronto Hotchkiss Brain Institute, University of Calgary	Has worked as paid consultant for: BMS & Otsuka & Lundbeck; Janssen; Pfizer
Tarek Rajji	MD FRCPC Canada Research Chair in Neurostimulation for Cognitive Disorders Chief, Geriatric Psychiatry Division Centre for Addiction and Mental Health Associate Professor, Department of Psychiatry University of Toronto	No conflict of interest to disclose
Irfan Mian	MD FRCPC, DABPN Assistant Professor, Department of Psychiatry, University of Toronto	No conflict of interest to disclose
David Crockford	MD, FRCPC, DABPBN, FAPA, FCPA Clinical Professor, Department of Psychiatry University of Calgary	No conflict of interest to disclose
Thomas Raedler	MD Associate Professor, Department of Psychiatry, University of Calgary	Honoraria, travel support and/or grant support fro Amgen, AstraZeneca, BMS, Boehringer-Ingelheim, Forum (EnVivo), Janssen, Lundbeck, Otsuka, Pfizer, Purdue, Roche, Sanofi Aventis, Sunovion, Valeant.
Tania Lecomte	PhD Professor, Universite de Montreal	No conflict of interest to disclose